Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery.

Literature DB >> 23396381

Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery.

Verena Pichler¹, Josef Mayr¹, Petra Heffeter^2,3, Orsolya Dömötör⁴, Éva A Enyedy⁴, Gerrit Hermann⁵, Diana Groza³, Gunda Köllensperger⁵, Markus Galanksi¹, Walter Berger^2,3, Bernhard K Keppler¹, Christian R Kowol^1,2.

Abstract

Maleimide-functionalised Pt(IV) complexes with highly selective binding properties to thiol groups were synthesised as precursors for binding of thiol-containing tumour-targeting molecules like human serum albumin.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23396381 PMCID： PMC4021452 DOI： 10.1039/c3cc39258a

Source DB: PubMed Journal: Chem Commun (Camb) ISSN： 1359-7345 Impact factor: 6.222

20 in total

1. Control of tumour vascular permeability.

Authors:
Journal: Adv Drug Deliv Rev Date: 1998-10-05 Impact factor: 15.470

Review 2. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

Authors: Markus Galanski; Michael A Jakupec; Bernhard K Keppler
Journal: Curr Med Chem Date: 2005 Impact factor: 4.530

3. Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design.

Authors: Rodney P Feazell; Nozomi Nakayama-Ratchford; Hongjie Dai; Stephen J Lippard
Journal: J Am Chem Soc Date: 2007-06-15 Impact factor: 15.419

4. Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro.

Authors: Jocelyn L Carr; Malcolm D Tingle; Mark J McKeage
Journal: Cancer Chemother Pharmacol Date: 2005-09-20 Impact factor: 3.333

5. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.

Authors: Shanta Dhar; Weston L Daniel; David A Giljohann; Chad A Mirkin; Stephen J Lippard
Journal: J Am Chem Soc Date: 2009-10-21 Impact factor: 15.419

Review 6. Current status and future prospects for satraplatin, an oral platinum analogue.

Authors: Hak Choy; Clinton Park; Min Yao
Journal: Clin Cancer Res Date: 2008-03-15 Impact factor: 12.531

7. Rapid biotransformation of satraplatin by human red blood cells in vitro.

Authors: Jocelyn L Carr; Malcolm D Tingle; Mark J McKeage
Journal: Cancer Chemother Pharmacol Date: 2002-05-22 Impact factor: 3.333

8. Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.

Authors: Verena Pichler; Seied M Valiahdi; Michael A Jakupec; Vladimir B Arion; Mathea S Galanski; Bernhard K Keppler
Journal: Dalton Trans Date: 2011-07-11 Impact factor: 4.569

Review 9. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer.

Authors: Evelina Miele; Gian Paolo Spinelli; Ermanno Miele; Federica Tomao; Silverio Tomao
Journal: Int J Nanomedicine Date: 2009-04-20

10. Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.

Authors: Michael R Reithofer; Seied M Valiahdi; Michael A Jakupec; Vladimir B Arion; Alexander Egger; Mathea Sophia Galanski; Bernhard K Keppler
Journal: J Med Chem Date: 2007-11-22 Impact factor: 7.446

18 in total

Review 1. Synthetic methods for the preparation of platinum anticancer complexes.

Authors: Justin J Wilson; Stephen J Lippard
Journal: Chem Rev Date: 2013-11-27 Impact factor: 60.622

Review 2. Platinum-induced neurotoxicity and preventive strategies: past, present, and future.

Authors: Abolfazl Avan; Tjeerd J Postma; Cecilia Ceresa; Amir Avan; Guido Cavaletti; Elisa Giovannetti; Godefridus J Peters
Journal: Oncologist Date: 2015-03-12

Review 3. The Platin-X series: activation, targeting, and delivery.

Authors: Uttara Basu; Bhabatosh Banik; Ru Wen; Rakesh K Pathak; Shanta Dhar
Journal: Dalton Trans Date: 2016-08-16 Impact factor: 4.390

Review 4. Harnessing albumin as a carrier for cancer therapies.

Authors: Ella N Hoogenboezem; Craig L Duvall
Journal: Adv Drug Deliv Rev Date: 2018-07-27 Impact factor: 15.470

5. Multifunctional α_vβ₆ Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting.

Authors: Anne C Conibear; Sonja Hager; Josef Mayr; Matthias H M Klose; Bernhard K Keppler; Christian R Kowol; Petra Heffeter; Christian F W Becker
Journal: Bioconjug Chem Date: 2017-08-10 Impact factor: 4.774

6. Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.

Authors: Helena Henke; Kushtrim Kryeziu; Jelena Banfić; Sarah Theiner; Wilfried Körner; Oliver Brüggemann; Walter Berger; Bernhard K Keppler; Petra Heffeter; Ian Teasdale
Journal: Macromol Biosci Date: 2016-05-12 Impact factor: 4.979

7. Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe.

Authors: Nikita Yabbarov; Elena Nikolskaya; Maria Sokol; Mariia Mollaeva; Margarita Chirkina; Irina Seregina; Mikhail Gulyaev; Yury Pirogov; Rem Petrov
Journal: Int J Mol Sci Date: 2022-03-14 Impact factor: 5.923

8. Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.

Authors: Yao-Rong Zheng; Kogularamanan Suntharalingam; Timothy C Johnstone; Hyunsuk Yoo; Wei Lin; Jamar G Brooks; Stephen J Lippard
Journal: J Am Chem Soc Date: 2014-06-06 Impact factor: 15.419

9. An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.

Authors: Josef Mayr; Petra Heffeter; Diana Groza; Luis Galvez; Gunda Koellensperger; Alexander Roller; Beatrix Alte; Melanie Haider; Walter Berger; Christian R Kowol; Bernhard K Keppler
Journal: Chem Sci Date: 2016-12-15 Impact factor: 9.825

10. EGFR-targeting peptide-coupled platinum(IV) complexes.

Authors: Josef Mayr; Sonja Hager; Bettina Koblmüller; Matthias H M Klose; Katharina Holste; Britta Fischer; Karla Pelivan; Walter Berger; Petra Heffeter; Christian R Kowol; Bernhard K Keppler
Journal: J Biol Inorg Chem Date: 2017-04-12 Impact factor: 3.358